Current through the 2024 Legislative Session.
Section 4127 - Regulations establishing standards for compounding sterile drug products(a) A pharmacy that compounds sterile drug products shall possess a sterile compounding pharmacy license as provided in this article.(b) The board shall adopt regulations in accordance with the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code) to establish policies, guidelines, and procedures to implement this article.(c) The board shall review any formal revision to General Chapter 797 of the United States Pharmacopeia and The National Formulary (USP-NF), relating to the compounding of sterile preparations, not later than 90 days after the revision becomes official, to determine whether amendments are necessary for the regulations adopted by the board pursuant to subdivision (b).Ca. Bus. and Prof'l. Code § 4127
Amended by Stats 2016 ch 484 (SB 1193),s 23, eff. 1/1/2017.Added by Stats 2013 ch 565 (SB 294),s 3, eff. 1/1/2014.